Anavex Financial Statements From 2010 to 2025

AVXL Stock  USD 9.20  0.23  2.44%   
Anavex Life financial statements provide useful quarterly and yearly information to potential Anavex Life Sciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Anavex Life financial statements helps investors assess Anavex Life's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Anavex Life's valuation are summarized below:
Market Capitalization
802.2 M
Earnings Share
(0.55)
There are over one hundred nineteen available fundamental signals for Anavex Life Sciences, which can be analyzed over time and compared to other ratios. We recommend to validate Anavex Life's prevailing fundamental drivers against the all of the trends between 2010 and 2025. Market Cap is expected to rise to about 448 M this year. Enterprise Value is expected to rise to about 323.1 M this year
Check Anavex Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anavex Life's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Other Operating Expenses of 67.3 M or Total Operating Expenses of 63.8 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.73. Anavex financial statements analysis is a perfect complement when working with Anavex Life Valuation or Volatility modules.
  
Check out the analysis of Anavex Life Correlation against competitors.

Anavex Life Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets163.7 M155.9 M66.8 M
Slightly volatile
Other Current Liabilities3.2 M5.6 M3.6 M
Slightly volatile
Total Current Liabilities18.5 M17.6 M7.3 M
Slightly volatile
Cash159.6 M152 M64.4 M
Slightly volatile
Cash And Short Term Investments159.6 M152 M64.4 M
Slightly volatile
Common Stock Total Equity94.1 K89.6 K55.1 K
Slightly volatile
Common Stock Shares Outstanding100.8 M96 M48.7 M
Slightly volatile
Liabilities And Stockholders Equity163.7 M155.9 M66.8 M
Slightly volatile
Other Stockholder Equity550.9 M524.7 M223.4 M
Slightly volatile
Total Liabilities18.5 M17.6 M7.7 M
Slightly volatile
Total Current Assets163.7 M155.9 M66.8 M
Slightly volatile
Common Stock102.6 K97.8 K56.9 K
Slightly volatile
Short and Long Term Debt Total93.5 K98.4 K468.1 K
Pretty Stable
Other Current Assets1.1 M1.1 M637.6 K
Slightly volatile
Short Term Debt72.9 K76.7 K107.7 K
Slightly volatile
Property Plant And Equipment Net1.5 K1.1 K1.3 K
Very volatile
Property Plant And Equipment Gross1.5 K1.1 K1.3 K
Very volatile
Net Receivables2.1 M2.8 M1.9 M
Slightly volatile
Capital Surpluse468.5 M446.2 M208 M
Slightly volatile
Other Liabilities3.5 M6.3 M4.5 M
Slightly volatile
Short and Long Term Debt73.2 K77 K176.8 K
Slightly volatile
Non Current Liabilities Other4.6 M5.1 M5.6 M
Slightly volatile
Long Term Debt Total264297324
Slightly volatile
Net Invested Capital89.1 M138.3 M63.8 M
Slightly volatile
Net Working Capital89 M138.3 M63.8 M
Slightly volatile
Capital Stock75.7 K97.8 K61 K
Slightly volatile

Anavex Life Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses67.3 M64.1 M28.9 M
Slightly volatile
Total Operating Expenses63.8 M60.8 M28.3 M
Slightly volatile
Selling General Administrative13.3 M12.7 M7.1 M
Slightly volatile
Research Development50.5 M48.1 M21.3 M
Slightly volatile
Selling And Marketing Expenses96 K106.2 K116.3 K
Slightly volatile
Non Recurring174.3 K202.8 K175.6 K
Slightly volatile
Interest Income8.8 M8.4 M2.1 M
Slightly volatile
Net Interest Income8.8 M8.4 MM
Slightly volatile

Anavex Life Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities17.8 M13.8 M22.3 M
Slightly volatile
End Period Cash Flow159.6 M152 M64.4 M
Slightly volatile
Begin Period Cash Flow182.4 M173.7 M58.9 M
Slightly volatile
Stock Based Compensation5.6 M10.9 M6.3 M
Slightly volatile
Sale Purchase Of Stock27.6 M24.5 M23.2 M
Slightly volatile
Change To Netincome20.8 M19.8 M8.8 M
Slightly volatile
Issuance Of Capital Stock12.3 M13 M21.9 M
Pretty Stable

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables3.8 M3.7 MM
Slightly volatile
Capex To Depreciation4.274.514.0458
Very volatile
Payables Turnover4.0E-45.0E-40.0122
Slightly volatile
Cash Per Share1.51.430.9094
Slightly volatile
Days Payables Outstanding843.2 K803.1 K723 K
Slightly volatile
Income Quality0.460.640.5665
Slightly volatile
Current Ratio8.377.977.2815
Slightly volatile
Capex Per Share3.0E-43.0E-43.0E-4
Pretty Stable
Average Receivables5.8 M5.5 M2.9 M
Slightly volatile
Interest Debt Per Share0.01320.01390.0705
Slightly volatile
Debt To Assets0.0060.00641.6088
Slightly volatile
Days Of Payables Outstanding843.2 K803.1 K723 K
Slightly volatile
Ebt Per Ebit1.40.981.2834
Slightly volatile
Long Term Debt To Capitalization0.00.00.2419
Slightly volatile
Quick Ratio8.377.977.3142
Slightly volatile
Net Income Per E B T1.111.151.0197
Slightly volatile
Cash Ratio8.167.777.0212
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9822
Slightly volatile
Debt Ratio0.0060.00641.6088
Slightly volatile

Anavex Life Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap448 M426.7 M281.6 M
Slightly volatile
Enterprise Value323.1 M307.7 M221.9 M
Slightly volatile

Anavex Fundamental Market Drivers

Cash And Short Term Investments132.2 M

Anavex Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
25th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

About Anavex Life Financial Statements

Anavex Life investors utilize fundamental indicators, such as revenue or net income, to predict how Anavex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue968.3 KM

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:
Check out the analysis of Anavex Life Correlation against competitors.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.55)
Return On Assets
(0.24)
Return On Equity
(0.38)
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.